NSC |
Compound |
Enrichment |
Correlation |
NSC 639514 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.0378615809326464 |
0.24694183 |
NSC 639520 |
Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.0378615809326464 |
0.2881716 |
NSC 639541 |
Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- |
0.0378615809326464 |
0.5188812 |
NSC 646159 |
Null |
0.0378615809326464 |
0.25784086 |
NSC 666123 |
Null |
0.0378615809326464 |
0.3264919 |
NSC 666787 |
Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate |
0.0378615809326464 |
0.44752343 |
NSC 679822 |
Naphth[2,3-d]oxazol-9(4H)-one, 2-methyl- 4-[4-(4-morpholinyl)phenylimino]- |
0.0378615809326464 |
-0.074911433 |
NSC 681641 |
Camptothecin Derivative |
0.0378615809326464 |
0.16262115 |
NSC 684901 |
Null |
0.0378615809326464 |
0.16394526 |
NSC 685981 |
1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- |
0.0378615809326464 |
0.21503296 |